STOCK TITAN

Moderna to Present at Upcoming Investor Conferences in March 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Moderna, Inc. (MRNA) is set to participate in upcoming investor conferences including TD Cowen 44th Annual Healthcare Conference and Barclays 26th Annual Global Healthcare Conference. The presentations will be live webcasted and available for replay on Moderna's website.
Positive
  • None.
Negative
  • None.

CAMBRIDGE, MA / ACCESSWIRE / February 28, 2024 / Moderna, Inc. (NASDAQ:MRNA), today announced its participation in the following upcoming investor conferences:

TD Cowen 44th Annual Healthcare Conference, on Wednesday March 6th at 1:30 pm ET.

Barclays 26th Annual Global Healthcare Conference, on Tuesday March 12th at 2:35 pm ET.

A live webcast of each of these presentations will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com. A replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation.

About Moderna

Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.


Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.

Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com

SOURCE: Moderna, Inc.



View the original press release on accesswire.com

Moderna, Inc. (MRNA) is participating in the TD Cowen 44th Annual Healthcare Conference on Wednesday, March 6th at 1:30 pm ET.

Moderna, Inc. (MRNA) is attending the Barclays 26th Annual Global Healthcare Conference on Tuesday, March 12th at 2:35 pm ET.

Investors can access the live webcast of Moderna, Inc. (MRNA) presentations under 'Events and Presentations' in the Investors section of the Moderna website at investors.modernatx.com.

The replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation.
Moderna Inc

NASDAQ:MRNA

MRNA Rankings

MRNA Latest News

MRNA Stock Data

Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
Health Technology, Biotechnology, Manufacturing, Biological Product (except Diagnostic) Manufacturing
US
Cambridge

About MRNA

moderna is pioneering messenger rna therapeutics™, an entirely new in vivo drug modality that produces human proteins or antibodies inside patient cells, which are in turn active intracellularly or secreted. this breakthrough platform addresses currently undruggable targets, and offers a superior alternative to existing drug modalities for a wide range of disease conditions. moderna has developed a broad intellectual property estate including more than 200 patent applications with more than 10,000 claims ranging from novel nucleotide chemistries to specific drug compositions. the company plans to develop and commercialize its innovative mrna drugs—initially for rare diseases and oncology—while partnering drug candidates in other therapeutics areas in order to rapidly deliver this innovation to patients. based in cambridge, massachusetts, moderna is privately held and was founded in 2010 by flagship venturelabs in association with leading scientists from boston children’s hospital a